Table 3.
Case–control analysis investigating the association between serum prediagnostic concentrations of PFOS, PFOA, PFHxS, and PFNA (categorized using quartiles among controls as cut points) and testicular germ cell tumors among active-duty U.S. Air Force servicemen (530 cases, 530 controls).
| PFOS | PFOA | PFHxS | PFNA | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Concentration (ng/mL) | a (95% CI) | b (95% CI) | Concentration (ng/mL) | a (95% CI) | b (95% CI) | Concentration (ng/mL) | a (95% CI) | b (95% CI) | Concentration (ng/mL) | a (95% CI) | b (95% CI) | ||||
| All subjects | |||||||||||||||
| First/only sample | |||||||||||||||
| 131/133 | 1.0 | 1.0 | 161/139 | 1.0 | 1.0 | 129/138 | 1.0 | 1.0 | 177/156 | 1.0 | 1.0 | ||||
| 18.4–29.3 | 116/135 | 1.0 (0.6, 1.5) | 1.2 (0.7, 1.9) | 4.46–5.87 | 115/126 | 0.7 (0.4, 1.0) | 0.7 (0.4, 1.0) | 2.2–3.6 | 118/133 | 1.0 (0.7, 1.4) | 0.9 (0.6, 1.4) | 0.7–0.9 | 172/151 | 0.9 (0.6, 1.2) | 0.8 (0.5, 1.2) |
| 29.4–42.2 | 153/131 | 1.4 (0.8, 2.3) | 1.9 (1.0, 3.4) | 5.88–7.85 | 121/137 | 0.7 (0.5, 1.0) | 0.7 (0.4, 1.1) | 3.7–7.0 | 146/128 | 1.2 (0.8, 1.7) | 1.2 (0.8, 1.8) | 1.0–1.2 | 91/101 | 0.7 (0.5, 1.0) | 0.6 (0.4, 1.0) |
| 130/131 | 1.2 (0.7, 2.0) | 1.8 (0.9, 3.6) | 133/128 | 0.8 (0.5, 1.2) | 0.8 (0.5, 1.4) | 137/131 | 1.1 (0.8, 1.6) | 1.1 (0.7, 1.7) | 90/122 | 0.5 (0.3, 0.8) | 0.4 (0.2, 0.7) | ||||
| — | — | — | — | — | — | — | — | ||||||||
| Subjects with two samples | |||||||||||||||
| First sample | |||||||||||||||
| 29/33 | 1.0 | 1.0 | 46/35 | 1.0 | 1.0 | 44/40 | 1.0 | 1.0 | 60/62 | 1.0 | 1.0 | ||||
| 18.4–29.3 | 49/54 | 1.1 (0.6, 2.2) | 1.2 (0.5, 2.5) | 4.46–5.87 | 46/58 | 0.6 (0.3, 1.0) | 0.6 (0.3, 1.2) | 2.2–3.6 | 47/49 | 0.9 (0.5, 1.6) | 0.8 (0.4, 1.5) | 0.7–0.9 | 71/52 | 1.4 (0.8, 2.4) | 1.0 (0.5, 1.9) |
| 29.4–42.2 | 65/61 | 1.5 (0.7, 3.1) | 1.6 (0.6, 4.0) | 5.88–7.85 | 47/52 | 0.7 (0.3, 1.3) | 0.8 (0.3, 1.8) | 3.7–7.0 | 50/52 | 0.8 (0.4, 1.7) | 0.8 (0.4, 1.8) | 1.0–1.2 | 24/35 | 0.7 (0.4, 1.4) | 0.4 (0.2, 1.1) |
| 44/39 | 1.6 (0.7, 3.6) | 2.0 (0.6, 6.4) | 48/42 | 0.9 (0.5, 1.8) | 1.0 (0.4, 2.7) | 46/46 | 0.9 (0.5, 1.8) | 0.8 (0.4, 1.8) | 32/38 | 0.8 (0.4, 1.8) | 0.4 (0.1, 1.3) | ||||
| — | — | — | — | — | — | — | — | ||||||||
| Second sample | |||||||||||||||
| 42/48 | 1.0 | 1.0 | 55/48 | 1.0 | 1.0 | 48/49 | 1.0 | 1.0 | 44/40 | 1.0 | 1.0 | ||||
| 13.3–21.2 | 38/46 | 1.1 (0.6, 1.9) | 1.5 (0.7, 3.3) | 4.26–5.65 | 52/46 | 1.0 (0.6, 1.8) | 1.0 (0.5, 2.0) | 2.4–3.7 | 42/46 | 1.1 (0.5, 2.1) | 1.1 (0.5, 2.4) | 0.8–1.0 | 47/49 | 0.9 (0.5, 1.7) | 0.6 (0.3, 1.5) |
| 21.3–33.5 | 50/47 | 1.9 (0.9, 4.1) | 2.8 (1.1, 7.0) | 5.66–7.55 | 39/49 | 0.7 (0.4, 1.4) | 0.6 (0.3, 1.4) | 3.8–6.2 | 41/46 | 1.0 (0.5, 1.9) | 0.8 (0.4, 1.6) | 1.1–1.5 | 50/52 | 0.7 (0.4, 1.5) | 0.3 (0.1, 0.9) |
| 57/46 | 2.6 (1.1, 6.4) | 4.6 (1.4, 15.1) | 41/44 | 0.7 (0.4, 1.5) | 0.6 (0.2, 1.6) | 56/46 | 1.4 (0.7, 2.8) | 1.2 (0.5, 2.5) | 46/46 | 0.6 (0.3, 1.4) | 0.2 (0.1, 0.8) | ||||
| — | — | — | — | — | — | — | — | ||||||||
| Both samples (first/second) | |||||||||||||||
| 53/67 | 1.0 | 1.0 | 72/65 | 1.0 | 1.0 | 72/73 | 1.0 | 1.0 | 92/73 | 1.0 | 1.0 | ||||
| 25/20 | 1.2 (0.5, 2.6) | 1.3 (0.6, 3.3) | 35/29 | 1.3 (0.7, 2.4) | 1.3 (0.6, 2.7) | 18/22 | 0.8 (0.4, 1.7) | 0.8 (0.4, 1.8) | 11/18 | 0.4 (0.2, 1.0) | 0.4 (0.2, 1.0) | ||||
| 27/27 | 2.3 (1.0, 5.6) | 2.2 (0.8, 5.9) | 20/28 | 0.6 (0.3, 1.4) | 0.5 (0.2, 1.3) | 19/16 | 1.3 (0.6, 3.0) | 1.1 (0.8, 6.9) | 39/41 | 0.7 (0.3, 1.3) | 0.6 (0.3, 1.2) | ||||
| 82/73 | 2.1 (1.1, 3.9) | 2.3 (1.02, 5.0) | 60/65 | 0.8 (0.5, 1.5) | 0.8 (0.4, 1.6) | 78/76 | 1.1 (0.7, 1.8) | 1.0 (0.5, 1.7) | 45/55 | 0.6 (0.3, 1.1) | 0.3 (0.1, 0.8) | ||||
Note: —, no data; CI, confidence interval; OR, odds ratio; PFAS, per- and polyfluoroalkyl substances; PFHxS, perfluorohexanesulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctanesulfonic acid.
ORs computed by conditional logistic regression of matched pairs with adjustment for military grade and number of deployments.
ORs computed by conditional logistic regression of matched pairs with adjustment for military grade, number of deployments, and all other PFAS (all PFAS covariates involve the same exposure metric and categorization as the PFAS of interest).